KAM

Krensavage Asset Management Portfolio holdings

AUM $189M
This Quarter Return
+7.52%
1 Year Return
+19.71%
3 Year Return
+56.44%
5 Year Return
+120.01%
10 Year Return
+215.64%
AUM
$295M
AUM Growth
+$295M
Cap. Flow
-$12M
Cap. Flow %
-4.06%
Top 10 Hldgs %
99.13%
Holding
14
New
2
Increased
3
Reduced
8
Closed
1

Top Buys

1
ENTA icon
Enanta Pharmaceuticals
ENTA
$3.38M
2
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
$3.03M
3
TVTX icon
Travere Therapeutics
TVTX
$2.04M
4
ALKS icon
Alkermes
ALKS
$1.51M
5
NXTC icon
NextCure
NXTC
$6.04K

Top Sells

1
BIIB icon
Biogen
BIIB
$14.2M
2
UTHR icon
United Therapeutics
UTHR
$5.33M
3
ALXN
Alexion Pharmaceuticals Inc
ALXN
$1.06M
4
ANAB icon
AnaptysBio
ANAB
$383K
5
REGN icon
Regeneron Pharmaceuticals
REGN
$332K

Sector Composition

1 Healthcare 97.53%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
REGN icon
1
Regeneron Pharmaceuticals
REGN
$61.5B
$45.9M 15.57% 82,104 -594 -0.7% -$332K
ALKS icon
2
Alkermes
ALKS
$4.78B
$41.4M 14.06% 1,688,841 +61,518 +4% +$1.51M
ENTA icon
3
Enanta Pharmaceuticals
ENTA
$180M
$41.4M 14.04% 939,650 +76,802 +9% +$3.38M
UTHR icon
4
United Therapeutics
UTHR
$13.8B
$39.4M 13.38% 219,690 -29,731 -12% -$5.33M
TARO
5
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$39.1M 13.28% 543,705 -3,934 -0.7% -$283K
BIIB icon
6
Biogen
BIIB
$19.4B
$33.8M 11.46% 97,523 -40,995 -30% -$14.2M
MCK icon
7
McKesson
MCK
$85.4B
$31.8M 10.81% 166,436 -1,204 -0.7% -$230K
SRGA
8
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$8.9M 3.02% 6,403,077 -46,331 -0.7% -$64.4K
IVC
9
DELISTED
Invacare Corporation
IVC
$7.28M 2.47% 901,712 -6,524 -0.7% -$52.7K
EGRX
10
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3.03M 1.03% +70,804 New +$3.03M
TVTX icon
11
Travere Therapeutics
TVTX
$1.56B
$2.04M 0.69% +140,000 New +$2.04M
ANAB icon
12
AnaptysBio
ANAB
$569M
$282K 0.1% 10,890 -14,800 -58% -$383K
NXTC icon
13
NextCure
NXTC
$13.5M
$252K 0.09% 31,355 +752 +2% +$6.04K
ALXN
14
DELISTED
Alexion Pharmaceuticals Inc
ALXN
– – -6,912 Closed -$1.06M